Homebiotech

biotech

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

biotech

New nanosensors make diagnostic procedures more sensitive

Jim Cornall - February 15, 2024

biotech

Watch: PhaseV at Bio-Europe

Jim Cornall - January 11, 2024

biotech

DeepMirror launches molecular drug design software

Jim Cornall - December 12, 2023

biotech

Video: Lithuanian company Caszyme at forefront of gene editing

Jim Cornall - November 14, 2023

biotech

Kuano raises £1.8M to accelerate quantum drug discovery

Jim Cornall - September 14, 2023

biotech

Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning

Jim Cornall - August 31, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

biotech

Revolutionary self-sensing electric artificial muscles

Jim Cornall - July 18, 2023

1...102103104 Page 103 of 104

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0